RE:Sales So Egrifta sales have suffered since the switch to F4/pandemic. This Q's number could largely be accounted for if sales of that drug have recovered to historical norms with some small growth in Trogarzo. Yep the breakdown matters.
jeffm34 wrote: Sales last quarter were 14.0M. This quarter improved by 35%. That's huge! Will be interesting to see the breakdown of sales.